DK1329462T3 - Fremgangsmåde til fremstilling af human serumalbumin, som inddrager opvarmningstrin - Google Patents

Fremgangsmåde til fremstilling af human serumalbumin, som inddrager opvarmningstrin

Info

Publication number
DK1329462T3
DK1329462T3 DK01978883T DK01978883T DK1329462T3 DK 1329462 T3 DK1329462 T3 DK 1329462T3 DK 01978883 T DK01978883 T DK 01978883T DK 01978883 T DK01978883 T DK 01978883T DK 1329462 T3 DK1329462 T3 DK 1329462T3
Authority
DK
Denmark
Prior art keywords
serum albumin
human serum
heating step
producing human
involves heating
Prior art date
Application number
DK01978883T
Other languages
Danish (da)
English (en)
Inventor
T Nouchi
H Mizokami
Y Tajima
Y Miyatsu
M Sakaguchi
K Yagi
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of DK1329462T3 publication Critical patent/DK1329462T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK01978883T 2000-10-24 2001-10-24 Fremgangsmåde til fremstilling af human serumalbumin, som inddrager opvarmningstrin DK1329462T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000324030A JP4798833B2 (ja) 2000-10-24 2000-10-24 加熱処理工程を含むヒト血清アルブミンの製造方法

Publications (1)

Publication Number Publication Date
DK1329462T3 true DK1329462T3 (da) 2007-01-22

Family

ID=18801621

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01978883T DK1329462T3 (da) 2000-10-24 2001-10-24 Fremgangsmåde til fremstilling af human serumalbumin, som inddrager opvarmningstrin

Country Status (12)

Country Link
US (1) US6908749B2 (ja)
EP (1) EP1329462B1 (ja)
JP (1) JP4798833B2 (ja)
KR (1) KR100839937B1 (ja)
CN (1) CN1313493C (ja)
AT (1) ATE348111T1 (ja)
AU (1) AU783638B2 (ja)
CA (1) CA2395590C (ja)
DE (1) DE60125218T2 (ja)
DK (1) DK1329462T3 (ja)
ES (1) ES2272548T3 (ja)
WO (1) WO2002034787A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE331735T1 (de) * 2000-10-24 2006-07-15 Chemo Sero Therapeut Res Inst Verfahren zur monomerisierung von humanen serumalbumin-polymeren
ATE382057T1 (de) 2001-06-28 2008-01-15 Novo Nordisk As Stabile formulierung von modifiziertem glp-1
AU2003281982A1 (en) * 2002-11-26 2004-06-18 Novo Nordisk A/S Process for purifying a fermentation-derived product
GB0305989D0 (en) * 2003-03-15 2003-04-23 Delta Biotechnology Ltd Agent
BRPI0410972C1 (pt) 2003-06-03 2021-05-25 Novo Nordisk As método para aumentar a vida de armazenagem de uma composição farmacêutica, composição farmacêutica, e, método para tratamento de hiperglicemia
JP2007524592A (ja) 2003-06-03 2007-08-30 ノボ・ノルデイスク・エー/エス 安定化された薬学的ペプチド組成物
DK1687019T3 (en) 2003-11-20 2018-02-12 Novo Nordisk As Propylene glycol peptide formulations that are optimal for production and use in injection devices
WO2005068489A1 (ja) * 2004-01-20 2005-07-28 Juridical Foundation The Chemo-Sero Therapeutic Research Institute 2価陽イオン存在下加熱処理によるヒト血清アルブミンの製造方法
PL1789434T3 (pl) 2004-08-31 2014-07-31 Novo Nordisk As Zastosowanie tris(hydroksymetylo)aminometanu do stabilizacji peptydów, polipeptydów i białek
BRPI0517341A (pt) 2004-11-12 2008-10-07 Novo Nordisk As composição farmacêutica estável em prateleira, métodos para a preparação de uma composição farmacêutica, para o tratamento de hiperglicemia, para o tratamento de obesidade, deficiência de célula beta, igt ou dislipidemia, para a preparação de uma solução estável de um composto glp-1, para a preparação de um composto glp-1 estável e para a preparação de uma composição farmacêutica estável em prateleira de um composto glp-1, solução estável de um composto glp-1, e, uso de uma solução estável de um composto glp-1
EP1966239A1 (de) 2005-12-22 2008-09-10 CSL Behring GmbH Oktanoatreduziertes human albumin
JP4936272B2 (ja) * 2006-02-13 2012-05-23 独立行政法人科学技術振興機構 バイオナノカプセルの効率的な精製法
EP2170356A1 (en) * 2007-06-25 2010-04-07 Fred Hutchinson Cancer Research Center Methods and compositions regarding polychalcogenide compositions
DK3429345T3 (da) 2016-10-04 2019-11-25 Albumedix Ltd Anvendelser af rekombinant gær-afledt serumalbumin
CN106749623B (zh) * 2016-12-09 2020-04-10 浙江大学 一种基于混合模式的扩张床吸附分离人血白蛋白方法
PL3474820T3 (pl) 2017-08-24 2024-05-13 Novo Nordisk A/S Kompozycje glp-1 i ich zastosowania
EP4069200A1 (en) 2019-12-04 2022-10-12 Albumedix Ltd Methods and compositions produced thereby
KR20220143037A (ko) 2020-02-18 2022-10-24 노보 노르디스크 에이/에스 Glp-1 조성물 및 이의 용도
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5071897A (ja) * 1973-11-07 1975-06-14
US4025500A (en) * 1974-06-06 1977-05-24 Baxter Laboratories, Inc. Preparation of albumin by fractionation of blood plasma or serum
IL66614A (en) 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
US5004688A (en) * 1988-04-15 1991-04-02 Phillips Petroleum Company Purification of hepatitis proteins
JP2926722B2 (ja) 1988-10-20 1999-07-28 吉富製薬株式会社 アルブミン製剤及びその製造方法
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
JPH04234326A (ja) * 1990-12-27 1992-08-24 Green Cross Corp:The アルブミン製剤及びその製法
JPH0671434A (ja) 1991-05-30 1994-03-15 Tadahiro Omi クリーンチャンバーの溶接方法
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JP3269504B2 (ja) * 1992-07-08 2002-03-25 三菱ウェルファーマ株式会社 ヒト血清アルブミンの製造方法
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
JPH07126182A (ja) * 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
JP3840674B2 (ja) * 1994-08-31 2006-11-01 三菱ウェルファーマ株式会社 遺伝子操作に由来するヒト血清アルブミンの精製方法
WO1998007873A1 (fr) * 1996-08-23 1998-02-26 Kirin Beer Kabushiki Kaisha Vecteurs de levure et procede de production de proteines les utilisant
JP2885212B2 (ja) * 1997-01-06 1999-04-19 吉富製薬株式会社 遺伝子操作由来のヒト血清アルブミンより得られる高純度ヒト血清アルブミン含有組成物

Also Published As

Publication number Publication date
DE60125218D1 (de) 2007-01-25
US20020182680A1 (en) 2002-12-05
CA2395590A1 (en) 2002-05-02
EP1329462B1 (en) 2006-12-13
ATE348111T1 (de) 2007-01-15
CA2395590C (en) 2012-12-11
JP2002128796A (ja) 2002-05-09
AU1093602A (en) 2002-05-06
AU783638B2 (en) 2005-11-17
EP1329462A4 (en) 2004-09-08
WO2002034787A1 (fr) 2002-05-02
CN1406246A (zh) 2003-03-26
KR20020065609A (ko) 2002-08-13
US6908749B2 (en) 2005-06-21
DE60125218T2 (de) 2007-09-20
ES2272548T3 (es) 2007-05-01
KR100839937B1 (ko) 2008-06-20
EP1329462A1 (en) 2003-07-23
CN1313493C (zh) 2007-05-02
JP4798833B2 (ja) 2011-10-19

Similar Documents

Publication Publication Date Title
DK1329462T3 (da) Fremgangsmåde til fremstilling af human serumalbumin, som inddrager opvarmningstrin
DE50214456D1 (de) Modifizierte l-nukleinsäure
DK1539966T3 (da) Fremgangsmåde til fremstilling af proteiner
DE60228961D1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des mop-b
IS5884A (is) Aðferð til framleiðslu á hreinu sítalóprami
ATE541857T1 (de) Optimierte fc-varianten und herstellungsverfahren dafür
DK1324776T3 (da) Koncentrerede proteinformuleringer med mindsket viskositet
IS7755A (is) Aðferð við framleiðslu á (S,S)-cis-2-benshýdríl-3-bensýlamínókínuklídín
IS6512A (is) Aðferð til framleiðslu á sítalóprami
IS2121B (is) Aðferð til framleiðslu á sítalóprami
IS6487A (is) Aðferð til framleiðslu á Sítalóprami
MXPA03000510A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos.
ATE453648T1 (de) Verfahren zur herstellung von hexahydrofuroc2,3- büfuran-3-ol
HK1051341A1 (en) Process for the automated manufacture of spectaclelenses
DE60042035D1 (de) Verfahren und zusammensetzungen zur herstellung von ophtalmischen linsen
IS7239A (is) Aðferð til framleiðslu á essítalóprami
EP1331273A4 (en) METHOD FOR PRODUCING PROTEIN HYDROLYSATES
ATE483691T1 (de) Verfahren zur herstellung von unsymmetrischen 4,6-bis(aryloxy)pyrimidin-derivaten
IS6526A (is) Aðferð til framleiðslu á sítalóprami
IS6529A (is) Aðferð til framleiðslu á sítalóprami
IS6605A (is) Aðferð til framleiðslu á sítalóprami
IS6293A (is) Aðferð til framleiðslu á sítalóprami
IS6528A (is) Aðferð til framleiðslu á sítalóprami
DK1001929T3 (da) Fremgangsmåde til fremstilling af 3-cyano-2,4-dihalogen-5-flour-benzoesyrer
EP1044688A4 (en) SOLUBILIZATION PROCESS FOR PYRIDONECARBOXYLIC ACID, SOLUBILIZER THEREFOR, AQUEOUS SOLUTION PREPARATIONS CONTAINING PYRIDONECARBOXYLIC ACID AND PROCESS FOR PRODUCING THE SAME